Company news

GeneDx Holdings Corp. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Sema4 to Participate at Two Upcoming Investor Conferences in February

February 2, 2022

Sema4 Announces Plans to Strengthen its Market Access Team to Drive Improved Commercial and Reimbursement Capabilities

January 31, 2022

Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform

January 17, 2022

Sema4 Announces Preliminary Revenue for the Fourth Quarter and Fiscal Year 2021

January 9, 2022

Sema4 to Participate at the 40th Annual J.P. Morgan Healthcare Conference in January

January 2, 2022

Sema4 Reports Third Quarter 2021 Financial Results and Business Highlights

November 14, 2021

Sema4 and Mount Sinai use Machine Learning to Improve Postpartum Hemorrhage Risk Prediction

November 3, 2021

Sema4 to Participate at Three Upcoming Investor Conferences in November

November 2, 2021

Sema4 to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021

October 18, 2021

Sema4 Appoints Computational Biology Expert Gustavo Stolovitzky as Chief Science Officer

September 12, 2021

Sema4 Launches Sema4 Elements™, a Portfolio of Data Science-Driven Products and Services to Support Reproductive and Generational Health

September 8, 2021

Sema4 to Participate at Two Upcoming Investor Conferences in September

August 29, 2021

Sema4 Reports Second Quarter 2021 Financial Results and Business Highlights

August 15, 2021

Avera Health and Sema4 Announce Collaboration to Advance Precision Oncology Care

August 10, 2021

Sema4 to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021

August 1, 2021

Sema4 to Participate at Two Upcoming Investor Conferences in August

July 27, 2021

Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company

July 21, 2021

Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors

July 6, 2021

CM Life Sciences and Sema4 Announce Release of Definitive Proxy Statement for July 21 Shareholder Meeting to Vote on Business Combination

July 1, 2021

Sema4 Appoints Andrew Kasarskis, Health Data Expert and Precision Medicine Scientist, as Chief Data Officer

June 16, 2021

Sema4 and CM Life Sciences Announce the Filing of Amended Preliminary Proxy Statement

June 9, 2021

AdventHealth and Sema4 Launch a Data-driven Precision Medicine Program to Optimize Patient Care and Outcomes

May 24, 2021

Sema4 to Participate in Upcoming Investor Conferences

May 23, 2021

Sema4 and CM Life Sciences Announce the Filing of the Schedule-14A Proxy Statement in Connection with the Proposed Merger

May 5, 2021

CM Life Sciences Announces Filing of Amended Annual Report on Form 10-K Relating to Restatement of Financial Statements in Accordance with Recent SEC Guidance

May 4, 2021

NorthShore and Sema4 Launch System-Wide Genomics Program to Improve Primary and Specialty Care with Data-Driven Insights

April 18, 2021

Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth

February 9, 2021

← Newer news releases

Calls

The 5 newest of 20 calls. Every call is listed under its year.

Decks

The 5 newest of 36 decks. Every deck is listed under its year.